Evaluation of a New Strategy to Approach the Transgender Sex Worker Populations and Their Clients for Access to a Preventive Sexual Health System Through the ORTIF Digital Teleconsultation Solution
E-PrevenT
2 other identifiers
observational
250
1 country
1
Brief Summary
The prevalence of HIV (Human Immunodeficiency Virus) and STIs (Sexually Transmitted Infections) is very high in the trans population, due to multifactorial components. The main risk factors for HIV in this population are unprotected receptive and insertive anal intercourse, multiple sexual partners, sex work, needles share for injecting drugs and hormones. Physical violence, sexual assault and lack of social and family support are supplementary social risk factors. Healthcare access is very limited in this socio-economic context. The population of transgender persons and their transmission chains (partners, clients, etc.) are highly exposed to HIV risk, but they are still "hidden" populations, not targeted by prevention programs. Innovative preventive strategies can improve sexual health services access for these specific populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2026
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2028
April 8, 2026
March 1, 2026
2 years
April 1, 2026
April 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of trans sex workers or clients who joined the E-PrevenT system during the study period.
Objective is to assess the access of the transgender sex worker population and their clients to an innovative preventive sexual health program, based on the ORTIF digital teleconsultation solution.
2 years
Secondary Outcomes (7)
Socio-epidemiological characteristics of users who join the E-PrevenT system.
2 years
Number of HIV/STI screening performed for trans SW or clients via the E-PrevenT system.
2 years
Number of positive HIV serologies and positive STI screenings out of the total number of tests performed in the study population
2 years
Number of trans sex workers or clients starting PrEP via the E-PrevenT system.
2 years
Number of trans sex workers trained in sexual health and STI prevention via E-PrevenT program
2 years
- +2 more secondary outcomes
Study Arms (2)
Population of the "escort clients" dating strategy
Dating site users (trans sex workers and their clients)
Population of the RDS strategy (Respondent Driven Sampling)
Seeds: trans SW on sex work followed-up in health programs of Bichat Acceptess- T. Seeds with regular follow-up and regular clients will be preferred. Fruits: clients invited by trans SW to participate to E-PrevenT programs
Eligibility Criteria
Population of the "escort clients" dating strategy: Dating site users (trans sex workers and their clients) Population of the RDS strategy (Respondent Driven Sampling) : Seeds: trans SW on sex work followed-up in health programs of Bichat Acceptess- T. Seeds with regular follow-up and regular clients will be preferred. Fruits: clients invited by trans sex workers to participate to E-PrevenT programs
You may qualify if:
- 'For population of E-prevent telemedicine service users :
- Individuals aged ≥18 years
- Registered on a trans escort-client dating website or having sexual relations with trans individuals in exchange for money
- Agreeing to complete at least one teleconsultation through the E-PrevenT program
- Agreeing to provide a phone number and an email address for the teleconsultation
- No verbal objection to participating in the study
- For population of trans individuals invited to collaborate in the study (seeds of the RDS strategy):
- Trans or non-binary individuals aged ≥18 years
- Engaged in sexual activity in exchange for money (sex work)
- Commitment to complete sexual health training sessions (twice per year)
- No verbal objection to participating in the study
You may not qualify if:
- Person under guardianship, curatorship or other French legal protections schemes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Bichat-Claude Bernard
Paris, Ap-hp DRCI, 75018, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valentina Isernia, MD
Assistance Publique Hopitaux de Paris
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2026
First Posted
April 8, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
May 1, 2028
Last Updated
April 8, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share